# RAI1

## Overview
The RAI1 gene encodes the retinoic acid induced 1 protein, a transcription factor that plays a pivotal role in regulating gene expression and maintaining transcriptional homeostasis, particularly in neuronal cells. This protein is characterized by its chromatin binding modules, including a plant homeodomain (PHD) finger and a GATA-1 like finger, which facilitate its interaction with chromatin and influence transcriptional dynamics (Darvekar2013A). RAI1 is predominantly localized in the nucleus, where it functions as both a transcriptional coactivator and repressor, depending on the target genes (Garay2020RAI1; CarmonaMora2010Functional). It is essential for synaptic scaling, a process crucial for neuronal stability, and is implicated in neurobehavioral disorders such as Smith-Magenis and Potocki-Lupski syndromes due to its role in brain development and mental health (Garay2020RAI1; Fragoso2014Expression).

## Structure
The RAI1 protein is characterized by specific chromatin binding modules, including a plant homeodomain (PHD) finger, which is a common motif in nuclear proteins. This motif consists of a two-strand antiparallel β-sheet followed by a C-terminal α-helix, stabilized by zinc atoms (Darvekar2013A). The PHD fingers of RAI1 are atypical, lacking a conserved tryptophan residue and not recognizing H3K4me2/3 marks, unlike other PHD subgroups (Darvekar2013A). RAI1's PHD fingers are linked to an N-terminal zinc finger structure similar to ePHD/ADD fingers found in other chromatin binding proteins, with a long loop between zinc ligands 2 and 3, forming a specific subgroup of ePHD/ADD modules (Darvekar2013A).

The protein also contains a GATA-1 like finger, which acts as a 'reader' module potentially recognizing specific histone marks (Darvekar2013A). The long loop region in RAI1, which is not conserved, may interact with other structural elements and is implicated in regulatory roles (Darvekar2013A). A missense mutation in this loop is associated with Smith-Magenis Syndrome, highlighting its functional importance (Darvekar2013A). The ePHD/ADD domain of RAI1 has the ability to bind nucleosomes, although other nucleosome or DNA binding activities in RAI1 have not been characterized (Darvekar2013A).

## Function
The RAI1 gene encodes a protein that functions as a transcription factor, playing a crucial role in regulating gene expression in healthy human cells. It is predominantly localized in the nucleus, where it influences transcriptional dynamics by interacting with chromatin. RAI1 acts as both a transcriptional coactivator and repressor, depending on the target genes, and is involved in chromatin binding (Garay2020RAI1; CarmonaMora2010Functional). The protein contains two main domains: an N-terminal half critical for its transactivational activity and a C-terminal half responsible for nuclear transportation, which includes nuclear localization signals and a zinc finger-like plant homeo domain (PHD) (CarmonaMora2010Functional).

RAI1 is essential for maintaining transcriptional homeostasis in response to changes in neuronal activity. It regulates activity-dependent nascent transcription, which is crucial for synaptic scaling, a process that adjusts synaptic strength to maintain neuronal stability (Garay2020RAI1). The protein's role in synaptic scaling is cell-autonomous to excitatory neurons, and its deficiency is linked to learning deficits in GABAergic interneurons (Garay2020RAI1). RAI1's involvement in transcriptional regulation is significant for proper brain development and mental health, as it is associated with neurobehavioral disorders like Smith-Magenis and Potocki-Lupski syndromes (Garay2020RAI1; Fragoso2014Expression).

## Clinical Significance
Mutations and alterations in the RAI1 gene are primarily associated with Smith-Magenis Syndrome (SMS) and Potocki-Lupski Syndrome (PTLS). SMS is a complex genomic disorder caused by haploinsufficiency of the RAI1 gene, often due to deletions or point mutations within the gene. This condition is characterized by intellectual disability, craniofacial abnormalities, self-injurious behavior, and sleep disturbances. Approximately 90% of SMS cases involve a deletion of chromosome 17p11.2, which includes the RAI1 gene, while about 10% are due to point mutations in RAI1 (CarmonaMora2010Functional; Vieira2011Detection).

RAI1 mutations in SMS can lead to either truncated proteins that localize to the cytoplasm or missense mutations that localize to the nucleus but fail to activate transcription, both resulting in impaired transcription factor activity (CarmonaMora2012RAI1). PTLS, on the other hand, is caused by a duplication of the 17p11.2 region, including RAI1, leading to symptoms such as developmental delay, intellectual disability, and autistic features (Elsea2011Smith–Magenis). The dosage sensitivity of RAI1 is evident as both deletion and duplication result in distinct syndromes with overlapping features (Elsea2011Smith–Magenis).

## Interactions
RAI1 is involved in various protein interactions that influence its role in transcriptional regulation. It interacts with the Rat1 exoribonuclease, where the interface involves ion-pair, hydrogen-bonding, and van der Waals interactions. Specific residues such as Lys848 in Rat1 and Asp372 in Rat1 form stabilizing interactions with Rai1, highlighting the structural basis of this interaction (Xiang2009Structure).

RAI1 also interacts with ZBTB17/MIZ1, identified through a yeast two-hybrid assay and confirmed by co-immunoprecipitation analysis. This interaction suggests a role in transcriptional regulation, although other potential interactors like BRD2 and SOGA3 were not confirmed due to experimental limitations (Loviglio2016Identification).

In the context of synaptic scaling, RAI1 interacts with transcriptional regulators such as TET3 and EHMT1/2, which are involved in synaptic plasticity. These interactions suggest that RAI1 may stabilize network activity through chromatin occupancy, influencing transcriptional responses to neuronal activation (Garay2020RAI1).

RAI1's role extends to plant biology, where it interacts with the coiled-coil domain of the PID3 protein in rice, contributing to blast disease resistance. This interaction is mediated by the OsRac1 GTPase, indicating a signaling pathway crucial for pathogen resistance (Zhou2019Importance).


## References


[1. (Darvekar2013A) Sagar Darvekar, Cecilie Rekdal, Terje Johansen, and Eva Sjøttem. A phylogenetic study of spbp and rai1: evolutionary conservation of chromatin binding modules. PLoS ONE, 8(10):e78907, October 2013. URL: http://dx.doi.org/10.1371/journal.pone.0078907, doi:10.1371/journal.pone.0078907. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0078907)

[2. (CarmonaMora2010Functional) Paulina Carmona-Mora, Carolina A Encina, Cesar P Canales, Lei Cao, Jessica Molina, Pamela Kairath, Juan I Young, and Katherina Walz. Functional and cellular characterization of human retinoic acid induced 1 (rai1) mutations associated with smith-magenis syndrome. BMC Molecular Biology, August 2010. URL: http://dx.doi.org/10.1186/1471-2199-11-63, doi:10.1186/1471-2199-11-63. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2199-11-63)

[3. (Xiang2009Structure) Song Xiang, Amalene Cooper-Morgan, Xinfu Jiao, Megerditch Kiledjian, James L. Manley, and Liang Tong. Structure and function of the 5′→3′ exoribonuclease rat1 and its activating partner rai1. Nature, 458(7239):784–788, February 2009. URL: http://dx.doi.org/10.1038/nature07731, doi:10.1038/nature07731. This article has 178 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature07731)

[4. (Elsea2011Smith–Magenis) Sarah H. Elsea and Stephen R. Williams. Smith–magenis syndrome: haploinsufficiency ofrai1results in altered gene regulation in neurological and metabolic pathways. Expert Reviews in Molecular Medicine, April 2011. URL: http://dx.doi.org/10.1017/S1462399411001827, doi:10.1017/s1462399411001827. This article has 67 citations and is from a peer-reviewed journal.](https://doi.org/10.1017/S1462399411001827)

[5. (Loviglio2016Identification) Maria Nicla Loviglio, Christine R. Beck, Janson J. White, Marion Leleu, Tamar Harel, Nicolas Guex, Anne Niknejad, Weimin Bi, Edward S. Chen, Isaac Crespo, Jiong Yan, Wu-Lin Charng, Shen Gu, Ping Fang, Zeynep Coban-Akdemir, Chad A. Shaw, Shalini N. Jhangiani, Donna M. Muzny, Richard A. Gibbs, Jacques Rougemont, Ioannis Xenarios, James R. Lupski, and Alexandre Reymond. Identification of a rai1-associated disease network through integration of exome sequencing, transcriptomics, and 3d genomics. Genome Medicine, November 2016. URL: http://dx.doi.org/10.1186/s13073-016-0359-z, doi:10.1186/s13073-016-0359-z. This article has 20 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/s13073-016-0359-z)

[6. (Zhou2019Importance) Zhuangzhi Zhou, Zhiqian Pang, Shengli Zhao, Lingli Zhang, Qiming Lv, Dedong Yin, Dayong Li, Xue Liu, Xianfeng Zhao, Xiaobing Li, Wenming Wang, and Lihuang Zhu. Importance of osrac1 and rai1 in signalling of nucleotide‐binding site leucine‐rich repeat protein‐mediated resistance to rice blast disease. New Phytologist, 223(2):828–838, April 2019. URL: http://dx.doi.org/10.1111/nph.15816, doi:10.1111/nph.15816. This article has 34 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1111/nph.15816)

[7. (Vieira2011Detection) Gustavo H Vieira, Jayson D Rodriguez, Paulina Carmona-Mora, Lei Cao, Bruno F Gamba, Daniel R Carvalho, Andréa de Rezende Duarte, Suely R Santos, Deise H de Souza, Barbara R DuPont, Katherina Walz, Danilo Moretti-Ferreira, and Anand K Srivastava. Detection of classical 17p11.2 deletions, an atypical deletion and rai1 alterations in patients with features suggestive of smith–magenis syndrome. European Journal of Human Genetics, 20(2):148–154, September 2011. URL: http://dx.doi.org/10.1038/ejhg.2011.167, doi:10.1038/ejhg.2011.167. This article has 16 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2011.167)

[8. (Garay2020RAI1) Patricia M. Garay, Alex Chen, Takao Tsukahara, Jean Carlos Rodríguez Díaz, Rafi Kohen, J. Christian Althaus, Margarete A. Wallner, Roman J. Giger, Kevin S. Jones, Michael A. Sutton, and Shigeki Iwase. Rai1 regulates activity-dependent nascent transcription and synaptic scaling. Cell Reports, 32(6):108002, August 2020. URL: http://dx.doi.org/10.1016/j.celrep.2020.108002, doi:10.1016/j.celrep.2020.108002. This article has 22 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2020.108002)

[9. (Fragoso2014Expression) Yara Dadalti Fragoso, Patrick N. Stoney, Kirsty D. Shearer, Angelo Sementilli, Sonia E. Nanescu, Pietro Sementilli, and Peter McCaffery. Expression in the human brain of retinoic acid induced 1, a protein associated with neurobehavioural disorders. Brain Structure and Function, 220(2):1195–1203, February 2014. URL: http://dx.doi.org/10.1007/s00429-014-0712-1, doi:10.1007/s00429-014-0712-1. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00429-014-0712-1)

[10. (CarmonaMora2012RAI1) Paulina Carmona-Mora, Cesar P. Canales, Lei Cao, Irene C. Perez, Anand K. Srivastava, Juan I. Young, and Katherina Walz. Rai1 transcription factor activity is impaired in mutants associated with smith-magenis syndrome. PLoS ONE, 7(9):e45155, September 2012. URL: http://dx.doi.org/10.1371/journal.pone.0045155, doi:10.1371/journal.pone.0045155. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0045155)